Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.
about
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.
@en
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.
@nl
type
label
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.
@en
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.
@nl
prefLabel
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.
@en
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.
@nl
P2093
P2860
P356
P1476
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes
@en
P2093
Qiuyang Zheng
Timothy Y Huang
Yingjun Zhao
P2860
P304
P356
10.1084/JEM.20171193
P407
P577
2018-05-08T00:00:00Z